Health Care & Life Sciences » Pharmaceuticals | Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Amphastar Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Core S&P Small Cap ETF
1,947,028
4.21%
552
0.08%
09/06/2018
Federated Kaufmann Fund
850,000
1.84%
0
0.24%
06/29/2018
Vanguard Total Stock Market Index Fund
842,375
1.82%
0
0%
07/31/2018
iShares Russell 2000 ETF
738,393
1.6%
-393
0.03%
09/06/2018
iShares Nasdaq Biotechnology ETF
540,864
1.17%
-7,077
0.11%
09/06/2018
TIAA-CREF Small Cap Equity Fund
477,400
1.03%
0
0.23%
05/31/2018
Vanguard Extended Market Index Fund
475,470
1.03%
0
0.01%
07/31/2018
PowerShares S&P Small Cap Health Care Portfolio
411,265
0.89%
26,147
0.62%
09/05/2018
Federated Kaufmann Small Cap Fund
403,531
0.87%
225,500
0.48%
06/29/2018
Vanguard Tax Managed Small Cap Fund
343,005
0.74%
4,800
0.09%
07/31/2018

About Amphastar Pharmaceuticals

View Profile
Address
11570 6th Street
Rancho Cucamonga California 91730
United States
Employees -
Website http://www.amphastar.com
Updated 07/08/2019
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.